Literature DB >> 2742503

Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.

P Eyer1, B Ladstetter, W Schäfer, J Sonnenbichler.   

Abstract

HLö 7, (pyridinium, 1-[[[4-(aminoarbonyl)pyridinio]methoxy]methyl] -2,4-bis- [(hydroxyimino)methyl] diiodide) has been shown to be efficacious in soman poisoning of mice even in the absence of atropine. To assess possible risks involved in the administration of HLö 7 its degradation products were analyzed at pH 2.5 and pH 7.4, respectively. At pH 2.5, where HLö 7 in aqueous solution was assumed to possess maximal stability, the predicted shelf life (10% decomposition) was about 8 years for 10 mM solutions at 8 degrees C. The apparent energy of activation was 117 kJ/mol. At pH 2.5, attack on the aminal-acetal bond predominated with formation of pyridine-2,4-dialdoxime, 2-cyanopyridine-4-aldoxime, isonicotinamide, and formaldehyde. At pH 7.4, primary attack on the 2-aldoxime group resulted in formation of an intermediate 2-cyano-4-aldoxime derivative which mainly decomposed into cyanide and the corresponding 2-pyridinone, 1-[[[4-(aminocarbonyl)-pyridinio]methoxy]methyl]-4- [(hydroxyimino)methyl] diiodide. In addition, liberated cyanide reacted with the intermediate 2-cyano-4-aldoxime derivative with formation of 2-pyridinone, 1-[[[4-(aminocarbonyl)-pyridinio]-methoxy]methyl]-6-cyano-4- [(hydroxyimino)methyl] diiodide. This cyanide sequestering pathway became significant only at high concentrations (10 mM) of HLö 7, and was marginal at 1 mM HLö 7.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742503     DOI: 10.1007/bf00334636

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  17 in total

1.  Stability of pyridine-2-aldoxime methiodide. II. Kinetics of deterioration in dilute aqueous solutions.

Authors:  R I ELLIN; J S CARLESE; A A KONDRITZER
Journal:  J Pharm Sci       Date:  1962-02       Impact factor: 3.534

2.  HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.

Authors:  J G Clement
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

3.  Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.

Authors:  J G Clement; J D Shiloff; C Gennings
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

4.  Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman.

Authors:  L P de Jong; G Z Wolring
Journal:  Biochem Pharmacol       Date:  1984-04-01       Impact factor: 5.858

5.  Hydrolysis of obidoxime chloride (Toxogonin). 3. Kinetics in neutral and alkaline solution.

Authors:  I Christenson
Journal:  Acta Pharm Suec       Date:  1972-09

6.  Formation of cyanide after i.v. administration of the oxime HI 6 to dogs.

Authors:  P Eyer; A Kawan; B Ladstetter
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

7.  Studies on the decomposition of the oxime HI 6 in aqueous solution.

Authors:  P Eyer; W Hell; A Kawan; H Klehr
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

8.  Effect of HI-6, applied into the cerebral ventricles, on the inhibition of brain acetylcholinesterase by soman in rats.

Authors:  D Sket; M Brzin
Journal:  Neuropharmacology       Date:  1986-01       Impact factor: 5.250

9.  The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man.

Authors:  O Wolthuis; R A Vanwersch; H J Van der Wiel
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

10.  Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo.

Authors:  J G Clement
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr
View more
  6 in total

1.  Synthesis and Molecular Properties of Nerve Agent Reactivator HLö-7 Dimethanesulfonate.

Authors:  Fu-Lian Hsu; Su Y Bae; Jack McGuire; Dana R Anderson; Stephanie M Bester; Jude J Height; Scott D Pegan; Andrew J Walz
Journal:  ACS Med Chem Lett       Date:  2019-03-28       Impact factor: 4.345

2.  Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.

Authors:  U Spöhrer; H Thiermann; R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 3.  Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.

Authors:  Biljana Antonijevic; Milos P Stojiljkovic
Journal:  Clin Med Res       Date:  2007-03

4.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.

Authors:  P Eyer; I Hagedorn; R Klimmek; P Lippstreu; M Löffler; H Oldiges; U Spöhrer; I Steidl; L Szinicz; F Worek
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  Interaction of obidoxime with sarin in aqueous solution.

Authors:  P G Waser; C M Alioth-Streichenberg; W H Hopff; R Portmann; W Hofmann; A Niederhauser
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

6.  Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice.

Authors:  J G Clement; A S Hansen; C A Boulet
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.